combining glp-1 receptor agonist with dpp-4 inhibitor not recommended guideline do combine inhibitors agonists guidance SGLT-2 inhibitors, GLP Frontiers | Mechanisms of action
Description
Gastrointestinal symptoms dominate

Tirzepatide follows a similar pattern, with indications spanning glycemic control and obesity treatment

Schoretsanitis, G., Weiler, S., Barbui, C., Raschi, E
Probiotics and prebiotics have generated interest due to their effects on gut microbiota composition

Diabetes Care (2020) 44(Supplement_1):S111S24
7% with placebo and 2% with dulaglutide
